Vine and Path are to become the latest big name apps to hit Windows Phone 8.
Vine and Path are to become the latest big name apps to hit Windows Phone 8.
Latest News:
The news was confirmed at Nokia’s launch of itsWindows Phone 8 smartphone, the Lumia 1020 yesterday.
According to Path, its app will use Nokia’s SDK to take full advantage of the 41-megapixel lens in the Lumia 1020.
Read more: Nokia officially shows off the Lumia 1020
“The Lumia 1020 combines the customisation inherent to Windows with the great graphics and optics that Nokia is known for,” says Path on the news.
“The device is equipped with a 41-megapixel camera - the best on the market - along with the Nokia Imaging SDK with 50 premium Nokia filters.”
Speaking to Pocket-Lint, vice president in charge of devices at Nokia Jo Harlow confirmed that both apps would be arriving on Microsoft’s mobile operating system.
Read more: Twitter launches Vine social video app on iOS
Nokia confirmed Vine would be arriving exclusively on its Windows Phone 8 devices later this year.
Path will not be exclusive though. No release date was confirmed.
The news was confirmed at Nokia’s launch of itsWindows Phone 8 smartphone, the Lumia 1020 yesterday.
According to Path, its app will use Nokia’s SDK to take full advantage of the 41-megapixel lens in the Lumia 1020.
Read more: Nokia officially shows off the Lumia 1020
“The Lumia 1020 combines the customisation inherent to Windows with the great graphics and optics that Nokia is known for,” says Path on the news.
“The device is equipped with a 41-megapixel camera - the best on the market - along with the Nokia Imaging SDK with 50 premium Nokia filters.”
Speaking to Pocket-Lint, vice president in charge of devices at Nokia Jo Harlow confirmed that both apps would be arriving on Microsoft’s mobile operating system.
Read more: Twitter launches Vine social video app on iOS
Nokia confirmed Vine would be arriving exclusively on its Windows Phone 8 devices later this year.
Path will not be exclusive though. No release date was confirmed.
No comments:
Post a Comment